Skip to main content
. 2022 Jul 5;65(9):721–730. doi: 10.1002/ajim.23410

Table 1.

Percent of 991,619 respondents (from September 8 through November 30, 2020) working outside the home ever tested for COVID‐19 and test positivity, by gender, age, and pre‐existing conditions

Ever tested for COVID‐19 COVID‐19 test positivity
Category N Weighted % (95% CI) N Weighted% (95% CI)
Working outside the home 410,800 41.4 (41.3, 41.6) 51,073 13.2 (13.0, 13.3)
Gender
Male 137,800 37.9 (37.7, 38.1) 17,046 13.2 (12.9, 13.4)
Female 264,152 45.5 (45.4, 45.7) 32,707 13.0 (12.9, 13.2)
Other 8654 39.0 (38.2, 39.2) 1294 16.4 (15.2, 17.6)
Age (years)
18–44 198,244 42.9 (42.7, 43.1) 25,097 13.3 (13.1, 13.5)
45–64 176,668 40.1 (39.9, 40.3) 22,278 13.4 (13.2, 13.6)
65 or older 35,619 38.1 (37.7, 38.5) 3674 11.1 (10.7, 11.5)
Pre‐existing conditions
Cancer 17,114 46.2 (45.6, 46.8) 2067 14.3 (13.6, 15.0)
Heart disease 16,701 44.9 (44.3, 45.5) 2306 15.7 (15.0, 16.5)
High blood pressure 110,176 42.4 (42.1, 42.6) 14,421 13.9 (13.6, 14.2)
Asthma 68,973 46.7 (46.3, 47.0) 8153 12.7 (12.3, 13.0)
Chronic lung disease such as COPD or emphysema 11,257 46.1 (45.3, 46.9) 1,520 16.4 (15.5, 17.4)
Kidney disease 6957 46.9 (45.8, 47.9) 1165 20.4 (19.2, 21.8)
Autoimmune disorder like rheumatoid arthritis or Crohn's disease 28,930 48.6 (48.1, 49.1) 3452 13.6 (13.1, 14,2)
Type 1 diabetes 4949 44.9 (43.7, 46.1) 1090 25.6 (23.9, 27.2)
Type 2 diabetes 36,736 44.4 (44.0, 44.8) 5705 16.9 (16.4, 17.4)
Weakened or compromised immune system 24,779 52.1 (51.5, 52.7) 3177 14.3 (13.7, 14.8)
None of the above pre‐existing conditions 205,180 39.5 (39.4, 39.7) 25,776 13.3 (13.1, 13.5)

Note: Actual participant numbers given but weights were applied to obtain adjusted percentages. The denominators for COVID‐19 test positivity are the number of respondents ever tested for COVID‐19.

Abbreviations: COPD, chronic obstructive pulmonary disease; COVID‐19, coronavirus disease 2019; 95% CI, 95% confidence interval.